Voyager Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | — | -116.8% | -171.2% |
| FY2016 | — | -290.4% | -282.7% |
| FY2017 | — | -709.1% | -697.6% |
| FY2018 | — | -1,195.6% | -1,158.8% |
| FY2019 | — | -49.5% | -41.8% |
| FY2020 | — | 16.0% | 21.5% |
| FY2021 | — | -196.8% | -190.3% |
| FY2022 | — | -124.3% | -113.4% |
| FY2023 | — | 48.8% | 52.9% |
| FY2024 | — | -104.1% | -81.3% |